Search

Pharmaceutical Industry Aptar Pharma Inaugurates New Site in India

| Editor: Dominik Stephan

Aptar Pharma inaugurates a new pharmaceuticals production near Mumbai/India, where the company produces mainly nasal and pulmonary drug delivery devices for the Indian market.

(Picture: Aptar)
(Picture: Aptar)

Mumbai/India – Aptar Pharma, an established player on the Indian pharmaceutical market since its foundation in 1999, has opened a new manufacturing site in India. With its new site at Rabale, Navi Mumbai, the company expects to provide world class quality products for the emerging Indian pharmaceutical market, speakers said. It includes an ISO 7 cleanroom where main production will focus on the DF30 metering valve platform for pMDIs and on spray pump assembly.

This article is protected by copyright. You want to use it for your own purpose? Contact us at support.vogel.de (ID: 31539000)